UnitedHealth Group (NYSE:UNH) Reaches New 1-Year High on Strong Earnings


Share on StockTwits

UnitedHealth Group Incorporated (NYSE:UNH)’s share price reached a new 52-week high on Thursday following a stronger than expected earnings report. The stock traded as high as $389.38 and last traded at $387.99, with a volume of 35510 shares changing hands. The stock had previously closed at $375.63.

The healthcare conglomerate reported $5.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.41 by $0.90. The firm had revenue of $70.20 billion during the quarter, compared to analysts’ expectations of $69.13 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The company’s revenue was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.72 EPS.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 23rd. Stockholders of record on Monday, March 15th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend was Friday, March 12th. UnitedHealth Group’s payout ratio is 33.09%.

A number of research analysts recently weighed in on the company. Bank of America reissued a “buy” rating and set a $415.00 target price on shares of UnitedHealth Group in a report on Thursday, January 21st. Truist raised their price target on shares of UnitedHealth Group from $420.00 to $450.00 in a research report on Wednesday. Barclays restated a “buy” rating and set a $405.00 target price on shares of UnitedHealth Group in a research report on Sunday, January 17th. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $404.00 to $409.00 and gave the company a “buy” rating in a research note on Thursday, January 21st. Finally, Truist Securities raised their target price on shares of UnitedHealth Group from $420.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday. Five research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $392.43.

In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, February 11th. The stock was sold at an average price of $335.80, for a total transaction of $1,679,000.00. Following the completion of the sale, the director now directly owns 153,953 shares of the company’s stock, valued at approximately $51,697,417.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 619 shares of the firm’s stock in a transaction that occurred on Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total value of $200,494.10. Following the completion of the transaction, the chief accounting officer now owns 31,908 shares in the company, valued at approximately $10,335,001.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,619 shares of company stock worth $3,292,774. Corporate insiders own 0.80% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Trust Asset Management LLC boosted its stake in shares of UnitedHealth Group by 80.8% in the 3rd quarter. Trust Asset Management LLC now owns 4,810 shares of the healthcare conglomerate’s stock worth $1,500,000 after buying an additional 2,150 shares during the last quarter. Wealth Alliance grew its stake in UnitedHealth Group by 6.5% in the 3rd quarter. Wealth Alliance now owns 7,371 shares of the healthcare conglomerate’s stock valued at $2,298,000 after purchasing an additional 453 shares during the period. OLD Mission Capital LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $439,000. IHT Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 35.5% in the 3rd quarter. IHT Wealth Management LLC now owns 4,547 shares of the healthcare conglomerate’s stock worth $1,418,000 after buying an additional 1,191 shares during the last quarter. Finally, Kingsview Wealth Management LLC increased its holdings in UnitedHealth Group by 15.5% during the third quarter. Kingsview Wealth Management LLC now owns 8,768 shares of the healthcare conglomerate’s stock worth $2,734,000 after buying an additional 1,177 shares during the last quarter. 86.03% of the stock is currently owned by institutional investors.

The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.82 and a current ratio of 0.82. The company has a market cap of $368.68 billion, a PE ratio of 22.40, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74. The company’s 50 day moving average price is $358.94 and its 200-day moving average price is $342.30.

UnitedHealth Group Company Profile (NYSE:UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

See Also: Bull Market

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.